The number of options is gradually increasing, most notably with oral formulations becoming available this year, and new drugs in the pipeline such as petrelintide, which promises slightly less weight loss than Wegovy or Tirzepatide, but minimal gastrointestinal side effects so far better tolerability
By week 48 (approximately one year), participants lost more than 24% of their starting weightan average of about 58 pounds.[4] This level of weight loss appears greater than what has been observed in studies of medications like Wegovy or Ozempic.[6,7] Additionally, nearly all 338 participants who took lower doses of retatrutide experienced weight reductions between 5% and 15%.[4] Even modest weight loss can have meaningful health benefits
The benefits claimedreversal of aging, improved cognition, enhanced metabolismremain unproven in controlled human trials
Some people notice appetite and energy improvements within 12 weeks
Insurance and Cost Insurance coverage varies based on specific plans and the condition being treated, and out-of-pocket costs can be high
JOIN US.